照护者信号问题对检测镰状细胞病儿童神经认知障碍的效用
美国血液学会镰状细胞病脑血管指南推荐使用信号问题进行神经认知困难筛查,但其临床效用尚未确立。本研究纳入421名8至17岁镰状细胞病儿童的照护者,询问7个信号问题,儿童完成神经认知和学业测量。结果显示,留级、学业成绩非以A/B为主、有学习困难史或照护者对其学习担忧的儿童更可能有显著神经认知障碍,且在所有测量中得分更低(均q<0.05)。学习困难史在检测显著神经认知障碍方面敏感性和特异性最高(敏感性0.64,特异性0.77)。
要点
- 照护者报告留级、学业成绩非以A/B为主、学习困难史或对学习担忧的儿童更可能有显著神经认知障碍(均q<0.05)。
- 学习困难史是检测显著神经认知障碍敏感性和特异性最高的信号问题(敏感性0.64,特异性0.77)。
- 照护者累积报告在人口学/临床因素之外改善了对神经认知障碍的预测。
核心结论
- 对全部镰状细胞病患者进行基于表现的筛查是识别神经认知或学业障碍最有效的手段,但使用照护者信号问题是一种简短且低成本的方法,可改善对需要支持的镰状细胞病患者的检测。
研究设计与样本
- 研究纳入421名8至17岁镰状细胞病儿童的照护者,其中62%为血红蛋白SS(HbSS)或血红蛋白S-β零(HbSβ0)地中海贫血,照护者回答7个信号问题,儿童完成基于表现的神经认知和学业测量。
主要发现
- 照护者报告留级、学业成绩非以A/B为主、有学习困难史或对学习担忧的儿童更可能有显著神经认知障碍,且在所有测量中得分更低(均q<0.05)。
- 学习困难史是检测显著神经认知障碍敏感性和特异性最高的信号问题(敏感性0.64,特异性0.77),对领域特异性损害的敏感性范围为0.56-0.77,特异性范围为0.63-0.72。
- 照护者累积报告在人口学/临床因素之外改善了对神经认知障碍的预测。
关键数值与推荐
- 显著神经认知障碍定义为在至少2项测量中低于常模均值超过1.5个标准差(SD)。
- 领域特异性损害定义为低于常模均值超过1.5个标准差(SD)。
- 美国血液学会镰状细胞病脑血管指南推荐使用信号问题进行神经认知困难监测筛查。
临床怎么用
- 美国血液学会镰状细胞病脑血管指南推荐使用信号问题进行监测筛查,尽管这些信号问题的临床效用尚未确立。
- 作者认为,使用照护者信号问题是一种简短且低成本的方法,可改善对需要支持的镰状细胞病患者的检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The American Society of Hematology cerebrovascular guidelines for sickle cell disease (SCD) recommend surveillance using signaling questions to screen for neurocognitive difficulties, although the clinical utility of these signaling questions has yet to be established. This study aimed to determine the clinical utility of caregiver signaling questions for detecting significant neurocognitive impairment (defined as >1.5 standard deviation [SD] below the normative mean on ≥2 measures) and domain-specific impairment (defined as >1.5 SD below the normative mean) in children and adolescents with SCD. A total of 421 caregivers of children with SCD aged 8 to 17 years (62% hemoglobin SS (HbSS) or hemoglobin S-beta zero (HbSβ0) thalassemia) were asked 7 signaling questions. Children completed performance-based neurocognitive and academic measures. Children who were reported to have repeated a grade, did not obtain primarily A/B grades in school, had a history of learning difficulties, or whose caregiver reported concern for their learning were more likely to have significant neurocognitive impairment and obtained lower scores across all measures (all q < 0.05). History of learning difficulties emerged as the most sensitive and specific signaling question for detecting significant neurocognitive impairment (sensitivity, 0.64; specificity, 0.77) and domain-specific impairment (sensitivity range, 0.56-0.77; specificity range, 0.63-0.72). Cumulative caregiver report improved prediction of neurocognitive impairment beyond demographic/clinical factors alone. Although performance-based screening for all patients with SCD is the most effective means to identify those with neurocognitive or academic impairment, use of caregiver signaling questions represents a brief and low-cost method to improve the detection of patients with SCD in need of support.
引用
- Dandar CM, Kearson L, Longoria JN, et al. Utility of caregiver signaling questions to detect neurocognitive impairment in children with sickle cell disease. Blood Adv. 2025. PMID: 39536283. doi:10.1182/bloodadvances.2024013958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。